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Humans live in harmony with much of the microbial
world, thanks to a sophisticated immune system. As
the first line of defense, macrophages engulf, digest,
and display foreign material, then recruit specialists to
eliminate potential threats. Yet infiltrators exist: cer-
tain fungi, viruses, parasites, and bacteria thrive within
sentinel macrophages. By scrutinizing the life styles of
these shrewd microbes, we can deduce how macro-
phages routinely mount an effective immune response.
The bimorphic life cycles of three pathogens have dra-
matic consequences for phagosome traffic. In the
transmissible state, Leishmania spp., Coxiella burnetii,
and Legionella pneumophila block phagosome matu-
ration; after a pregnant pause, replicative forms
emerge and thrive in lysosomes.
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Pathogens as Tools for Macrophage
Biologists
Pathogens employ a variety of strategies to survive in macro-
phages (1) (Figure 1). Toxoplasma gondii completely avoids
fusion with the endosomal pathway; during invasion of mam-
malian cells, parasites direct the assembly of porous vacuoles
that exclude host transmembrane proteins, presumably ren-
dering their compartments invisible to the fusion machinery.
In contrast, Mycobacterium tuberculosis stalls maturation of
its phagosome and replicates within a recycling, early endo-
somal compartment. Even more bold are Leishmania spp.,
Coxiella burnetii, and Legionella pneumophila: These patho-
gens flourish in acidic lysosomal vacuoles, although not one
arrives directly, or stays permanently.
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To succeed, Leishmania spp., C. burnetii, and L. pneumo-
phila employ biphasic life cycles. Cellular differentiation likely
evolved in response to two selective pressures: the need to
multiply and to be transmitted to a new host. To meet this
dual challenge, all three pathogens alternate between an in-
tracellular replicative state and a transmissible form that can
tolerate harsh environments. In macrophages, the parasites’
developmental cycle has dramatic consequences for phago-
some biogenesis (Figure 1B). In the transmissible state, Le-
ishmania spp., C. burnetii, and L. pneumophila block phago-
some maturation; after a pregnant pause, replicative forms
emerge that thrive in phagolysosomes.
Despite their distinct ecological habitats, Leishmania spp., C.
burnetii, and L. pneumophila apply a similar strategy to sur-
mount the macrophage barrier in humans. Recent concep-
tual and technical advances by laboratories studying one of
the three microbes suggest a comparative approach is op-
portune. By considering that convergent evolution made
these diverse pathogens members of the same exclusive
club, we may gain fresh insight into how macrophages gov-
ern phagosome maturation and degrade foreign matter. After
describing briefly their natural reservoirs and associated dis-
eases, we review the experimental evidence that L. pneumo-
phila, C. burnetii, and Leishmania spp. alternately avoid and
exploit lysosomes to multiply in macrophages, and speculate
on virulence mechanisms that may be shared.
Separate Habitats, Diverse Diseases
Leishmania: Prevalent in South America, the Leishmania
are trypanosomatid protozoans transmitted among mammals
by an insect vector (2). When sand flies bite an infected ani-
mal, macrophages harboring the pathogen are ingested with
the blood meal. Released parasites multiply in the insect
midgut, and these can be delivered during subsequent feed-
ings to a new mammalian host. When humans are bitten,
some Leishmania species establish self-limiting cutaneous
lesions, whereas others spread systemically and cause kala
azar, a fatal visceral disease.
Coxiella burnetii: C. burnetii is a gram-negative bacterium
that infects a variety of winged, scaled and hoofed animals
and, more rarely, the people in their proximity (3). For ex-
ample, when infected female sheep give birth, they shed a
large burden of micro-organisms. Consequently, humans can
inhale the obligate intracellular bacterium in aerosols of con-
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Figure1: To avoid death in the lysosomes, pathogens short-circuit phagosome maturation. (A) Mycobacterium tuberculosis stalls
maturation of its phagosome and replicates within an early endosomal compartment, whereas Toxoplasma gondii assembles a vacuole that
excludes host transmembrane proteins. (B) The transmissible forms of Leishmania spp., Coxiella burnetii, and Legionella pneumophila
establish vacuoles that are separate from the endosomal pathway, but later differentiate to replicative forms that thrive in acidic lysosomes.
taminated soil. When ingested by alveolar macrophages, the
microbe can proliferate and disseminate, causing an acute
flu–like syndrome known as Q fever. For an unlucky few, the
infection progresses to chronic endocarditis or hepatitis.
Legionella pneumophila: Close cousins of C. burnetii, the
legionellae are common in soil and water, where they thrive
within amoebae (4). Humans typically become infected with
L. pneumophila by inhaling contaminated aerosols gener-
ated by man-made devices, such as whirlpools or insti-
tutional air conditioners. This facultative intracellular pathogen
can colonize alveolar macrophages and, if local or systemic
host defenses are impaired, establish a life-threatening pneu-
monia. However, microbes are not transmitted from one per-
son to another. Since humans are an evolutionary dead-end,
it is apparent that pathogenic L. pneumophila emerged from
communities of fresh-water amoebae (4). In fact, amoebae
may be a natural reservoir for a variety of macrophage patho-
gens, including C. burnetii, M. avium, Burkholderia, Listeria,
and Franciscella (5–7).
Dimorphic Life Cycles
Leishmania: To alternate between insects and mammals,
parasites differentiate. Within the midgut of sand flies, Leish-
mania replicate as promastigotes, cells that are long, slender,
flagellated, and covered by a dense filamentous glycocalyx.
The predominant component of its coat is lipophosphoglycan
(LPG), a glycosylphosphatidylinositol-linked polymer of phos-
phorylated disaccharide repeats. Among other traits, LPG
mediates adherence to the midgut wall, protects the parasite
from digestive enzymes and, as discussed below, blocks
phagosome maturation (8, 9). When ingested by macro-
phages at the site of an insect bite, the protozoa differentiate
to the amastigote form, which lack flagella and LPG, and rep-
licate within acidic phagolysosomes. Upon return to the in-
sect midgut during a subsequent blood meal, amastigotes
that are released from macrophages differentiate to the pro-
mastigote form, and the cycle continues. In broth cultures,
promastigotes become highly infectious in stationary phase
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(10), but the signal transduction pathway that controls differ-
entiation in vivo is not known.
Coxiella burnetii: C. burnetii also alternates between two
morphologically distinct cell types (11, 12). The spore-like
form, known as the small cell variant (SCV), tolerates extreme
environments, whereas the large cell variant (LCV) replicates
within eukaryotic cells. The architecture of LCVs is typical of
gram-negative bacilli; in contrast, SCVs are roughly half their
size, and their contents appear condensed. More recent mol-
ecular approaches confirmed that SCVs and LCVs are spe-
cialized cell types. Abundant in SCVs are a histone H1 homo-
log and ScvA, a 30-amino-acid basic peptide that localizes
to condensed chromatin (13, 14). Conversely, homologs of
the sigma factor RpoS and the translation factor EF-Tu are
predominantly expressed by LCVs (15, 16). As described be-
low, an acidic pH is required for SCV differentiation to the
LCV form, but how the reciprocal event is regulated is not
known. To a first approximation, the SCV state differs from
the stationary phase of Escherichia coli, judging from its low
quantity of the stationary phase sigma factor, RpoS (16).
Legionella pneumophila: The bimorphic life cycle of L.
pneumophila reflects the selective pressures to replicate
within and be transmitted among fresh-water amoebae.
Growth conditions affect the physiology of this facultative intra-
cellular bacterium (4, 17). Unlike bacteria cultured in broth, L.
pneumophila released from macrophages or amoebae are
short, wide, motile rods with a smooth, thick cell wall and
abundant b-hydroxybutyrate. When compared to broth cul-
tures, intracellular bacteria express a different profile of genes,
proteins, membrane fatty acids, and lipopolysaccharide.
Growth in amoebae also increases L. pneumophila resistance
to biocides and antibiotics, invasion of mammalian cells, and
virulence in mice (18–21). Thus, cellular differentiation enables
L. pneumophila to alternate between extracellular and intra-
cellular environments.
Recently, a regulatory model for L. pneumophila morphogen-
esis has been generated by genetic and molecular studies of
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broth and macrophage cultures. When amino acids become
scarce, L. pneumophila accumulates the second messenger
(p)ppGpp (22). As a result, the two-component regulator
LetA/LetS and the sigma factors RpoS and FliA coordinate
cellular differentiation to a transmissible form (23, 24). Ac-
cordingly, when conditions deteriorate, intracellular bacteria
stop replicating and instead express a pore-forming cytotoxin
(25, 26) to escape the host, osmotic resistance to tolerate
environmental stress, motility to disperse, and factors that
block phagosome maturation to establish a protected niche
within the next phagocyte (27). When intracellular bacteria
sense conditions favorable for growth, they down-regulate
traits that promote transmission and convert to the replicative
form.
The ‘Pregnant Pause’ Strategy for Survival
For all three pathogens, morphogenesis from an extracellular
infectious form to an intracellular replicative phenotype oc-
curs within a protected vacuole in macrophages. After a
period of one to several hours, a new cell type emerges that
is equipped not merely to tolerate but to multiply within the
harsh lysosomal compartment. Thus, as detailed below,
macrophage delivery of these pathogens to lysosomes bene-
fits its intruder, not its host.
Leishmania: In macrophages, the infectious forms of Leish-
mania spp. establish vacuoles that are poorly fusogenic
(Table1). For example, by 2h after formation, nearly 100% of
Table1: Colocalization of young and mature pathogen vacuoles with markers of the endosomal pathway
Assay Coxiella Legionella Leishmania spp Amastigote
burnetii pneumophila Promastigote
2h .6h ,8h .8h ,3d .3d
Fluid phase markers
Lucifer Yellow π (43)
Texas Red-ovalbumin –(49, 51) π (51)
FITC-dextran π (43) π (51) π (34)
BSA conjugates low (28, 30) π (34)
Electron dense colloids – (38) π (38, 41) – (47, 48, 76) π (33)
Endosomal proteins
5ƒ nucleotidase π (42) – (77)
Transferrin receptor – (47, 49)
LAMP-1 π (43) – (49, 74, 77) π (51) low (30) π (34, 35)
LAMP-2 π (43) π (34)
Proton ATPase π (43)
Cathepsin D π (43) – (49) π (51) π (34, 35)
Acid phosphatase –(38) π (38, 41) – (48)
rab7 low (50, 74) low (30) π (35)
pH
Acridine orange π (43)
DAMP π (36)
FITC ,5.0 (41, 44) ,7.4 (51, 52) ,5.5 (51) , 5.0 (36)
Inhibition of growth
Bafilomycin A π (43) π (51)
Lysosomotropic amines π (43, 45) π (51)
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phagosomes containing latex beads acquire BSA-gold from
the endocytic pathway, but only ,50% of those harboring
promastigotes do so (28). A series of genetic and biochem-
ical studies have demonstrated that the capacity of certain
Leishmania spp. to block phagosome maturation is conferred
by LPG, its unique surface glycoconjugate (9, 28, 29). Mu-
tants that lack LPG are readily delivered to lysosomes and are
killed by macrophages (29–31). In particular, during the first
hour of infection of J774 macrophages, almost 100% of the
phagosomes formed by lpg2 mutant Leishmania donovani
promastigotes accumulate Rab7 or LAMP-1, whereas only
,50% of the vacuoles bearing wild-type promastigotes ac-
quire these late endosomal features (30). In a reciprocal ex-
periment, Holm and colleagues found that 30min after inges-
tion by J774 macrophages, yeasts colocalize with LAMP-1,
but yeasts opsonized with LPG do not (32).
The composition and production of LPG is developmentally
regulated by Leishmania, and its pattern determines phago-
some maturation (9). When cultured in broth, Leishmania
major promastigotes become highly infectious in the station-
ary phase, concomitant with an increase in the average num-
ber of LPG repeating units and modifications of the side
chain termini (10). In macrophages, when promastigotes dif-
ferentiate to amastigotes, LPG expression is down-regulated.
As a result, the parasites traffic to lysosomes, their replication
niche (33) (Table1). For example, 5days after infection of
mouse macrophages, Leishmania mexicana vacuoles con-
tain LAMP-1, b-glucuronidase, and cathepsin D, and they are
accessible to endocytic probes (34). Similarly, 2days after
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entering macrophages, L. donovani amastigotes colocalize
with rab7, LAMP-1, and cathepsins B, D, H, and L (35). As
expected for lysosomal compartments, vacuoles harboring
Leishmania amazonensis amastigotes are ,pH5.0 (36). The
ability to culture amastigotes in broth will expedite analysis
of the mechanisms that equip parasites to replicate in lyso-
somes (37).
Coxiella burnetii: Similar to the Leishmania, the infectious
form of C. burnetii perturbs phagosome maturation (38). Ex-
ploiting ScvA as a morphogenesis marker (14), Howe and
Mallavia monitored in parallel both the fate and the cellular
differentiation of bacteria immediately after infection. Fifteen
minutes after uptake by J774 macrophages, ,70% of the
intracellular bacteria remained in the SCV form, a fraction
equal to that of the inoculum. Unlike killed bacteria, the ma-
jority remained separate from the lysosomal compartment,
as judged by colocalization with acid phosphatase or endo-
cytosed thorium dioxide. By 1h, ,80% of the C. burnetii had
differentiated to the metabolically active LCV form. Mean-
while, from 1 to 6h postinfection, the fraction of lysosomal
bacteria increased from ,30% to ,60%. Differentiation to
the replicative form likely occurs prior to delivery to lyso-
somes, as SCV activation in vitro is more efficient at pH5.5
than at pH7.0 or 4.5 (38). Although correlative, the data are
consistent with a model in which SCVs produce factors to
block phagosome-lysosome fusion.
Whether the capacity to perturb phagosome maturation in
macrophages is unique to the SCV form has not been tested
rigorously. In fact, in a chicken egg model, SCVs and LCVs
are equally infectious (11), but how accurately growth in eggs
predicts a capacity to survive and replicate either in macro-
phages or an immunocompetent host is not clear. Another
indication that LCVs may be infectious is that 2h after Vero
cells are infected with a mixed population of C. burnetii, intact
LCVs are found in phagosomes that also contain SCVs (39).
However, since wild-type L. pneumophila can chaperone avi-
rulent trafficking mutants to a replication niche (40), this ex-
periment does not establish that LCVs can alter phagosome
biogenesis. More detailed experiments can determine
whether C. burnetii must delay phagosome maturation to es-
tablish a replication niche in macrophages, and whether this
attribute is unique to SCVs.
After differentiation to the LCV form, C. burnetii thrives in
lysosomes (Table1) (41–43). One detailed immunofluor-
escence microscopic analysis of a variety of infected eukary-
otic cell lines demonstrated that after 40h of infection, C.
burnetii is located in vacuoles that contain the vacuolar pro-
ton ATPase, the late endosomal and lysosomal proteins
LAMP-1 and LAMP-2, and the lysosomal protease cathepsin
D (43). In addition, compartments harboring the bacteria are
accessible to fluid-phase endocytosis probes, they accumu-
late the lysosomotropic dye Acridine Orange, and their lu-
mens are ,pH4.5–5.0 (41, 43, 44). Furthermore, neutraliza-
tion of the endosomal compartment by treatment with the
proton ATPase inhibitor bafilomycin A or the weak bases am-
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monium chloride, chloroquine, or methylamine inhibits C.
burnetii growth (43, 45).
Legionella pneumophila: Building on the pioneering work
of Horwitz, several investigators have confirmed that, for sev-
eral hours after formation, phagosomes harboring L. pneu-
mophila remain separate from the lysosomal compartment
(Table1). Lysosomes labeled by acid phosphatase cytochem-
istry or by endocytosis of electron-dense colloids do not fuse
with L. pneumophila phagosomes aged less than 6h (46–
48), and the late endosomal and lysosomal proteins Rab7,
LAMP-1, LAMP-2, and cathepsin D are not typical of bac-
terial phagosomes younger than 3h (47, 49, 50). Further-
more, young L. pneumophila vacuoles do not accumulate
material from the early endosomal compartment, including
transferrin receptors, the endocytic tracers Texas Red-ovalbu-
min and Alexa Fluor-streptavidin, or the lipid dye CM-DiI,
probes that are readily detected in phagosomes containing
polystyrene beads or avirulent bacteria (47, 49). Therefore,
in macrophages, L. pneumophila establishes a vacuole that
remains functionally separate from the endosomal network
for at least 6h.
In contrast, during their 10–15h replication period, L. pneu-
mophila phagosomes acquire lysosomal characteristics
(Table1) (51). By 18h postinfection, 70% of the vacuoles con-
tain LAMP-1 and 50% accumulate quantities of cathepsin D
and fluorescent endocytic probes that can be detected by
fluorescence microscopy. Moreover, whereas nascent L.
pneumophila phagosomes remain at a neutral pH, by 16–
20h after infection, those vacuoles that are accessible to fluid
phase tracers are also acidic (51, 52). Thus, as they mature, L.
pneumophila replication vacuoles merge with the lysosomal
compartment. Four experimental results indicate that the
lysosomal compartment promotes, rather than inhibits, L.
pneumophila growth (51). Vacuoles that contain greater than
five bacteria also contain LAMP-1; bacteria within endocytic
vacuoles can respond to a metabolic inducer by expressing
a reporter Green Fluorescent Protein; neutralization of the en-
dosomal pathway with the proton ATPase inhibitor bafilomy-
cin A1 arrests bacterial replication; and replicating L. pneu-
mophila obtained from macrophages are acid tolerant. To-
gether, the data indicate that, like Leishmania and C. burnetii,
L. pneumophila differentiates to a replicative form that thrives
within macrophage lysosomes.
Autophagy as an Alternate Route to
Lysosomes
The immature phagosomes established by some pathogens
may be delivered to the lysosomes by autophagy (Figure 2).
In this cellular response to stress or developmental cues (53),
eukaryotic cells engulf cytoplasmic material and organelles,
including mitochondria, within folds of the endoplasmic retic-
ulum, or other as yet unidentified intracellular membranes.
Autophagosomes then acquire LAMP-1, the proton ATPase,
and lysosomal hydrolases, and the vacuolar contents are de-
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Figure2: In macrophages, autophagy may act as a quality
control mechanism that recognizes and redirects isolated
pathogen vacuoles to the lysosomal compartment. See text
for details.
graded. Several observations suggest that L. pneumophila
traffic by autophagy to the lysosomal compartment: Endo-
plasmic reticulum encloses L. pneumophila vacuoles 4–6h
after formation (54, 55); Gsa7p (56), a ubiquitin-E1-like en-
zyme of the autophagy pathway, colocalizes with young L.
pneumophila vacuoles (Amer and Swanson, unpublished
observations); and conditions that stimulate autophagy pro-
mote association of the endoplasmic reticulum with the
pathogen vacuole and also modestly stimulate bacterial
growth (55). Finally, as expected for autophagosome matu-
ration, the pathogen compartment slowly acquires lysosomal
traits (51). Autophagy may also direct Leishmania to lyso-
somes, as vacuoles harboring amastigotes contain detect-
able calnexin, an endoplasmic reticulum protein, and they
slowly accumulate cytosolic markers by a process sensitive
to 3-methyladenine, an inhibitor of autophagy (57). Two other
gram-negative pathogens, Brucella abortus and Porphyro-
monas gingivalis, reside within vacuoles that are enveloped
by endoplasmic reticulum and acquire LAMP-1 (58, 59). Per-
haps in macrophages, autophagy acts as a quality control
mechanism for phagosome maturation. When pathogens as-
semble nonfusigenic vacuoles, the autophagy pathway may
recognize the aborted phagosomes and redirect them to the
lysosomal compartment.
Adaptation to Lysosomes
To replicate in the macrophage’s most noxious organelle is
an astonishing feat. Studies of C. burnetii metabolism re-
vealed how pathogens can profit from the lysosomes’ acidity.
Transport and catabolism of glutamate by freshly explanted
extracellular C. burnetii is optimal at pH3–5 and poor at neu-
tral pH (60). These and other data indicate that intracellular
C. burnetii exploit the proton gradient across its cytoplasmic
membrane to drive critical biochemical reactions (45, 61, 62).
How lysosomal Leishmania, C. burnetii, and L. pneumophila
cope with the array of degradative enzymes remains a mys-
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tery. The majority of cell biological studies demonstrating co-
localization of pathogens with lysosomal proteases relied on
immunological methods, techniques that do not address bio-
logical activity. However, infection by C. burnetii of J774 cells
does not reduce total activity of lysosomal proteases (41).
To investigate whether pathogens exploit the proteases of
macrophage lysosomes to generate amino acids needed for
replication requires more sophisticated probes of macro-
phage biology.
Virulence factors that perturb phagosome maturation
In the course of evolution, Leishmania, C. burnetii, and L.
pneumophila have learned how to short-circuit phagosome
maturation; therefore, they can direct us to critical regulators of
this cellular pathway. One clue to how pathogens block phago-
some maturation is the limited range of their virulence factors.
Legionella pneumophila blocks its own progression to lyso-
somes with no apparent effect on phagosome acidification or
maturation elsewhere in the phagocyte (40, 52). Likewise,
when J774 macrophages are fed a mixture of latex beads and
virulent Leishmania, 90% of the beads still traffic to the endo-
somal compartment (28). Therefore, the virulence factors that
block delivery of these pathogenic vacuoles to lysosomes act
locally, most likely by altering either the phagosome’s mem-
brane or its membrane-associated regulatory factors.
Of the microbial factors that prevent phagosome maturation,
the best understood is LPG. The current model for its mech-
anism of action incorporates the observed effects of purified
LPG on target membranes (63). When L. donovani LPG par-
titions into bilayers, the membranes are stabilized and be-
come refractory to fusion with enveloped viruses. Accord-
ingly, LPG may inhibit phagosome maturation by increasing
the energy required to alter the bilayer structure to form fu-
sion intermediates. Intercalation of LPG into phagosomal
membranes also inhibits protein kinase C activity and in-
creases actin accumulation, two processes antagonistic to
phagosome maturation (32, 64).
In light of LPG’s potent inhibition of phagosome maturation,
it is tempting to speculate that lipopolysaccharide serves an
analogous function for the two gram-negative pathogens. By
this model, developmental regulation of lipopolysaccharide
would account for the pregnant pause of the phagosome
maturation. Although lipopolysaccharide (LPS) variants of C.
burnetii do occur (65, 66), they do not behave as elements
of a developmental pathway. Phase 1 forms are isolated from
patients or infected animals, have complex oligosaccharide
side chains, are serum-resistant, and are infectious in a
guinea pig model of disease. After passage in tissue culture
or chicken eggs, Phase II organisms emerge; these cells ex-
press a less elaborate and more hydrophobic form of LPS
(65), are serum-sensitive, adhere more readily to cultured
macrophages, but are avirulent in guinea pigs (66). However,
since the reciprocal conversion has not been reported, and
both phases can establish persistent infections (67), there is
no evidence that LPS modifications account for the traffick-
ing pattern of C. burnetii in macrophages.
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Modifications of L. pneumophila lipopolysaccharide have also
beencorrelated to virulence,but a link togrowthphaseormem-
brane trafficking has not been described. Legionella pneumo-
phila produces an unusually hydrophobic lipopolysaccharide
(LPS) that may facilitate its intracellular lifestyle (68). An LPS
phase-variant mutant of L. pneumophila was isolated after re-
peat passage (69). Unlike wild-type, the mutant grew poorly
within HL60 monocytic cells and in guinea-pig lungs. Further-
more, reversion of the mutant to the wild-type LPS was pro-
moted during animal infections. Therefore, that a development-
ally regulated phase variation of LPS contributes to L. pneumo-
phila pathogenesis remains an attractive hypothesis.
The best characterized determinant of phagosome biogen-
esis of L. pneumophila is the Dot/Icm type IV secretion sys-
tem. As discussed by Vogel in this issue (70), this specialized
transport apparatus apparently acts during phagocytosis to
establish the L. pneumophila replication vacuole. It is reason-
able to predict that C. burnetii uses a similar strategy, as its
genome encodes multiple homologs of the dot/icm genes.
As yet, substrates of the Dot/Icm secretion complex that alter
the fate of L. pneumophila or C. burnetii phagosomes have
not been identified. Also contributing to L. pneumophila sur-
vival in macrophages is a Dot-independent activity (49). A
surprising observation is that formalin-killed bacteria and vi-
able dot mutant bacteria establish phagosomes that readily
acquire LAMP-1, but do not accumulate cathepsin D, nor
Texas Red-ovalbumin, CM-DiI, or Alexa Fluor-streptavidin, en-
docytic probes readily acquired by phagosomes containing
E. coli or polystyrene beads. Therefore, in the transmissible
form, L. pneumophila secretes a Dot/Icm-dependent factor
and expresses a formalin-resistant surface factor to perturb
phagosome maturation.
As observed for Leishmania, once L. pneumophila establish-
es a protected vacuole, virulence factors that block phago-
some maturation are no longer needed. L. pneumophila that
express DotA prior to contact with macrophages, but not
after, still replicate during the primary infection cycle (50).
and when dotA mutants share a phagosome with wild-type
bacteria, they replicate (40). In addition, recent genetic
studies of L. pneumophila virulence identified a two-compo-
nent regulator, LetA/S, that induces transmission traits, in-
cluding motility, cytotoxicity, and lysosome evasion, yet is dis-
pensable for intracellular replication (24). Consistent with this
genetic separation of the transmission and replication pheno-
types, L. pneumophila that are replicating in macrophages
down-regulate flagella production and cytotoxicity, and they
traffic to the lysosomal compartment (22, 26, 27, 51). There-
fore L. pneumophila transmission traits are dispensable for
intracellular replication, a phenomenon analogous to the
down-regulation of LPG by Leishmania spp. during differen-
tiation from the transmissible to the replicative form.
Odd Entrances May Point to Mechanism
Coiling phagocytosis: Macrophages and amoebae engulf
L. pneumophila within coils of plasma membrane (71,72).
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Coiling phagocytosis has been observed for a number of
other microbes, including Leishmania donovani (73). Based
on their detailed ultrastructural studies, Rittig and colleagues
postulated that coiling phagosomes occur when the mem-
branes of pseudopods that surround a particle fail to fuse
(74). Accordingly, plasma membrane whorls may be a prod-
uct of the same microbial activities that inhibit fusion with
lysosomes, although this hypothesis has not been tested di-
rectly.
Perturbation of the actin cytoskeleton: Another striking
aspect of pathogen entry that may provide insight to viru-
lence mechanisms is aberrant actin dynamics. Isberg and
colleagues have found that L. pneumophila can induce dif-
fuse actin ruffles and formation of macropinosomes that con-
tain GPI-linked proteins and also GM1-gangliosides, a hall-
mark of cholesterol-rich membranes (75). Similarly, C. bur-
netii induce dramatic and transient actin rearrangements in
THP-1 monocytes (75), but their consequences for phago-
some structure or function have not been determined. Finally,
Leishmania LPG stimulates a prolonged accumulation of ac-
tin filaments around the phagosome, a trait that correlates to
isolation from the endosomal pathway (32). How particular
actin rearrangements affect pathogen fate is not known.
The formidable microbicidal activities of macrophages also
function as strong selective pressures for variants that can
replicate intracellularly. Leishmania spp., Coxiella burnetii,
and Legionella pneumophila employ a ‘pregnant pause’
strategy to acquire the time needed to differentiate to a form
that can exploit the harsh lysosomal compartment as a rep-
licative niche. Knowledge of the tactics of macrophage
pathogens provides a valuable conceptual framework for fu-
ture research to identify and characterize virulence factors
that perturb phagosome maturation. Because of their sim-
plicity relative to mammalian cells, together with their more
facile genetics, microbes promise to be powerful experimen-
tal tools to investigate macrophage cell biology.
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